C. Pharand

Guidelines for the Management of Spontaneous Intracerebral Hemorrhage

Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack

Reduced Platelet Activity Is Associated With Early Clot Growth and Worse 3-Month Outcome After Intracerebral Hemorrhage

A Comparison of Clopidogrel Responsiveness in Patients With Versus Without Chronic Renal Failure

Assays of different aspects of haemostasis – what do they measure?

Determination of residual antiplatelet activity of clopidogrel before neuraxial injections

Methods for evaluation of platelet function

Aspirin failure in patients presenting with acute cerebrovascular ischaemia

Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update

Platelets and acute cerebral infarction

The influence of clinical characteristics, laboratory and inflammatory markers on ‘high on-treatment platelet reactivity’ as measured with different platelet function tests

Antiplatelet Drugs

Analysis of Myocardial Infarction Using Discrete Wavelet Transform

Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes

Response variability to aspirin as assessed by the platelet function analyzer (PFA)-100

Value of platelet pharmacogenetics in common clinical practice of patients with ST-segment elevation myocardial infarction

Early Platelet Transfusion Improves Platelet Activity and May Improve Outcomes After Intracerebral Hemorrhage

Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association

A Wavelet-Based ECG Delineator: Evaluation on Standard Databases

Obesity and Altered Aspirin Pharmacology

Reduced Platelet Activity is More Common than Reported Anti-Platelet Medication Use in Patients with Intracerebral Hemorrhage

Automatic P-wave analysis of patients prone to atrial fibrillation

Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors

Aspirin and Antiplatelet Agent Resistance

The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition

Interindividual variability in the response to oral antiplatelet drugs: a position paper of the Working Group on antiplatelet drugs resistance appointed by the Section of Cardiovascular Interventions of the Polish Cardiac Society, endorsed by the Working Group on Thrombosis of the European Society of Cardiology

Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy

Wavelet transforms and the ECG: a review

The use of the VerifyNowsystem to monitor antiplatelet therapy: A review of the current evidence

The genetics of antiplatelet drug resistance

Failure of the Platelet Function Assay (PFA)-100 to detect antiplatelet agents

Platelet Function Tests in Clinical Cardiology

Platelet Function Testing in Contemporary Clinical and Interventional Practice

The Role of Aspirin in Cardiovascular Prevention

2011 Update to The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines

Guidelines for the Management of Spontaneous Intracerebral Hemorrhage

Aspirin and Antiplatelet Agent Resistance

Application of deep convolutional neural network for automated detection of myocardial infarction using ECG signals

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

Expert position paper on the role of platelet function testing in patients undergoing percutaneous coronary intervention

2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes

Comparison of methods to evaluate clopidogrel-mediated platelet inhibition after percutaneous intervention with stent implantation

Comparison of four tests to assess inhibition of platelet function by clopidogrel in stable coronary artery disease patients

Wavelet time entropy, T wave morphology and myocardial ischemia

A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease